- Home
- ASYS vs TIL Comparison
ASYS vs TIL Comparison
Compare ASYS & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- TIL
- Stock Information
- Founded
- ASYS 1981
- TIL 2018
- Country
- ASYS United States
- TIL United States
- Employees
- ASYS N/A
- TIL N/A
- Industry
- ASYS Industrial Machinery/Components
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- TIL Health Care
- Exchange
- ASYS Nasdaq
- TIL Nasdaq
- Market Cap
- ASYS 59.4M
- TIL 230.1M
- IPO Year
- ASYS N/A
- TIL 2021
- Fundamental
- Price
- ASYS $4.60
- TIL $23.87
- Analyst Decision
- ASYS
- TIL Buy
- Analyst Count
- ASYS 0
- TIL 5
- Target Price
- ASYS N/A
- TIL $119.00
- AVG Volume (30 Days)
- ASYS 39.6K
- TIL 310.5K
- Earning Date
- ASYS 08-06-2025
- TIL 08-12-2025
- Dividend Yield
- ASYS N/A
- TIL N/A
- EPS Growth
- ASYS N/A
- TIL N/A
- EPS
- ASYS N/A
- TIL N/A
- Revenue
- ASYS $90,826,000.00
- TIL N/A
- Revenue This Year
- ASYS N/A
- TIL N/A
- Revenue Next Year
- ASYS $28.60
- TIL N/A
- P/E Ratio
- ASYS N/A
- TIL N/A
- Revenue Growth
- ASYS N/A
- TIL N/A
- 52 Week Low
- ASYS $3.20
- TIL $9.85
- 52 Week High
- ASYS $6.96
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- ASYS 56.56
- TIL 46.54
- Support Level
- ASYS $4.55
- TIL $23.38
- Resistance Level
- ASYS $4.94
- TIL $26.91
- Average True Range (ATR)
- ASYS 0.25
- TIL 3.25
- MACD
- ASYS 0.00
- TIL -0.32
- Stochastic Oscillator
- ASYS 66.34
- TIL 31.75
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.